Be part of our success story
There are many reasons to invest in us – a company aiming for quality growth and diversification. As a result of our leading positions, we have pioneering knowledge and experience in markets with strong margins.
Visit our Why invest page to find more about the advantages of investing in Merck KGaA, Darmstadt, Germany.
30% of our total capital is publicly traded, while the remainder is held by the general partner E. Merck KG, Darmstadt, Germany (the holding company for the founding family). The number of shares in free float amounts to 129.2 million, while the theoretical number of shares is 434.8 million.
General Share Data
|ISIN||DE 000 659 9905|
|Type of shares||Shares without nominal value, bearer share. One share, one vote.
|Authorized capital||EUR 168,014,927.60|
|Theoretical number of shares*||434,777,878|
|Market segment||Prime Standard|
|Deutsche Börse Index||DAX|
|Sector||Pharmaceutical & Healthcare|
|Official trading||Xetra, Frankfurt (Germany)|
|OTC (Germany)||Regional stock exchanges|
|First listing date||October 20, 1995|
|Issue price / no. shares issued||39,999,999 shares at DM 54.00 (EUR 27.61)|
|Share Split||1:2 as of June 30, 2014|
|Fiscal year end||December 31st|
|Paying Agent for Dividend||Deutsche Bank AG|
|Major indices||DAX, SXXP, MSER, BE500, SXXE, MSPE, SXDP, MCXP (detailed list)|
The Merck KGaA Darmstadt, Germany established a Sponsored Level I American Depository Receipt (ADR) program on 26 July 2017, which trades over-the-counter (OTC) in the United States.
|* The calculation of the theoretical number of shares is based on the fact that the general partner's equity is not represented by shares. As the share capital of EUR 168,014,927.60 is divided into 129,242,252 shares, the corresponding calculation for the general partner´s capital of EUR 397,196,314.35 leads to 305,535,626 theoretical shares.